Funder
National Institute of Allergy and Infectious Diseases
National Health and Medical Research Council
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference38 articles.
1. The 10 x ’20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020;Clin Infect Dis,2010
2. Federal Task Force on Combating Antibiotic-Resistant Bacteria. National Action Plan For Combating Antibiotic-Resistant Bacteria, 2020–2025. Available at: https://aspe.hhs.gov/pdf-report/carb-plan-2020-2025 [accessed 12 February 2021].
3. CARB-X. CARB-X combating antibiotic-resistant bacteria. 2021. Available at: https://carb-x.org/ [accessed 18 February 2021].
4. Generating robust and informative nonclinical in vitro and in vivo bacterial infection model efficacy data to support translation to humans;Bulitta;Antimicrob Agents Chemother,2019
5. Considerations for dose selection and clinical pharmacokinetics/pharmacodynamics for the development of antibacterial agents;Rizk;Antimicrob Agents Chemother,2019
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献